Trial Profile
Preoperative 68Ga-PSMA PET/CT on the efficacy of lymph node metastasis in clinical advanced/metastatic renal cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Renal cancer
- Focus Diagnostic use
- 17 Jul 2018 New trial record